Prothymosin α1 effects, in vitro, on the antitumor activity and cytokine production of blood monocytes from colorectal tumor patients

This publication has 30 references indexed in Scilit:

• Prothymosin α1 modulates lymphokine-activated killer cell activity and IL-2 production by peripheral blood lymphocytes from melanoma patients in vitro
  International Journal of Immunopharmacology, 1995
• Effects of granulocyte‐monocyte colony‐stimulating factor (GM‐CSF) on expression of adhesion molecules and production of cytokines in blood monocytes and ovarian cancer‐associated macrophages
  International Journal of Cancer, 1995
• Thymosin α1 effects, in vitro, on lymphokine-activated killer cells from patients with primary immunodeficiencies: Preliminary results
  International Journal of Immunopharmacology, 1994
• Anti‐tumor effect of combined treatment with thymosin alpha 1 and interleukin‐2 after 5‐fluorouracil in liver metastases from colorectal cancer in rats
  International Journal of Cancer, 1994
• Monocyte Activation Following Systemic Administration of Granulocyte-Macrophage Colony-Stimulating Factor
  Journal of Immunotherapy, 1994
• Promotion of murine antitumour activity by prothymosin α treatment: I. Induction of tumoricidal peritoneal cells producing high levels of tumour necrosis factor α
  Cancer Immunology, Immunotherapy, 1992
• The origin and function of tumor-associated macrophages
  Immunology Today, 1992
• Thymosin alpha 1 modulates the expression of high affinity interleukin-2 receptors on normal human lymphocytes
  International Journal of Immunopharmacology, 1990
• Characterization of the immunoregulatory properties of thymosin alpha 1 on interleukin-2 production and interleukin-2 receptor expression in normal human lymphocytes
  International Journal of Immunopharmacology, 1989
• Tumoricidal activity of human monocytes activated in vitro by free and liposome-encapsulated human lymphokines.
  Journal of Clinical Investigation, 1983